• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《中国 2019 年冠状病毒病(COVID-19)的临床特征:系统评价和荟萃分析》

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.

机构信息

School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 510080, China.

School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 510080, China; State Key Laboratory of Food Nutrition and Safety, Tianjin University of Science & Technology, Tianjin, China; College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin, China.

出版信息

J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.

DOI:10.1016/j.jinf.2020.03.041
PMID:32283155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7151416/
Abstract

OBJECTIVE

To better inform efforts to treat and control the current outbreak with a comprehensive characterization of COVID-19.

METHODS

We searched PubMed, EMBASE, Web of Science, and CNKI (Chinese Database) for studies published as of March 2, 2020, and we searched references of identified articles. Studies were reviewed for methodological quality. A random-effects model was used to pool results. Heterogeneity was assessed using I. Publication bias was assessed using Egger's test.

RESULTS

43 studies involving 3600 patients were included. Among COVID-19 patients, fever (83.3% [95% CI 78.4-87.7]), cough (60.3% [54.2-66.3]), and fatigue (38.0% [29.8-46.5]) were the most common clinical symptoms. The most common laboratory abnormalities were elevated C-reactive protein (68.6% [58.2-78.2]), decreased lymphocyte count (57.4% [44.8-69.5]) and increased lactate dehydrogenase (51.6% [31.4-71.6]). Ground-glass opacities (80.0% [67.3-90.4]) and bilateral pneumonia (73.2% [63.4-82.1]) were the most frequently reported findings on computed tomography. The overall estimated proportion of severe cases and case-fatality rate (CFR) was 25.6% (17.4-34.9) and 3.6% (1.1-7.2), respectively. CFR and laboratory abnormalities were higher in severe cases, patients from Wuhan, and older patients, but CFR did not differ by gender.

CONCLUSIONS

The majority of COVID-19 cases are symptomatic with a moderate CFR. Patients living in Wuhan, older patients, and those with medical comorbidities tend to have more severe clinical symptoms and higher CFR.

摘要

目的

通过全面描述 COVID-19 来更好地指导当前疫情的治疗和控制工作。

方法

我们检索了截至 2020 年 3 月 2 日发表的 PubMed、EMBASE、Web of Science 和 CNKI(中国数据库)中的研究,并检索了已确定文章的参考文献。对研究进行了方法学质量评价。使用随机效应模型对结果进行汇总。使用 I2 评估异质性。使用 Egger 检验评估发表偏倚。

结果

纳入了 43 项涉及 3600 例患者的研究。在 COVID-19 患者中,发热(83.3% [95%CI 78.4-87.7%])、咳嗽(60.3% [54.2-66.3%])和乏力(38.0% [29.8-46.5%])是最常见的临床症状。最常见的实验室异常表现为 C 反应蛋白升高(68.6% [58.2-78.2%])、淋巴细胞计数降低(57.4% [44.8-69.5%])和乳酸脱氢酶升高(51.6% [31.4-71.6%])。计算机断层扫描最常报告的发现是磨玻璃影(80.0% [67.3-90.4%])和双侧肺炎(73.2% [63.4-82.1%])。总体估计严重病例和病死率(CFR)的比例分别为 25.6%(17.4-34.9)和 3.6%(1.1-7.2)。严重病例、来自武汉的患者和老年患者的 CFR 和实验室异常更为严重,但性别之间的 CFR 没有差异。

结论

大多数 COVID-19 病例有症状,CFR 适中。居住在武汉、老年患者和有合并症的患者往往有更严重的临床症状和更高的 CFR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/7a85d0bfe240/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/b9d1a674cc01/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/3ae7a08d49ba/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/27e443cb0512/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/7a85d0bfe240/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/b9d1a674cc01/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/3ae7a08d49ba/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/27e443cb0512/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12fe/7151416/7a85d0bfe240/gr4_lrg.jpg

相似文献

1
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.《中国 2019 年冠状病毒病(COVID-19)的临床特征:系统评价和荟萃分析》
J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.
2
Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses.新型冠状病毒(SARS-CoV-2)感染人类的临床、实验室和影像学特征及结局:系统综述和一系列荟萃分析。
PLoS One. 2020 Sep 17;15(9):e0239235. doi: 10.1371/journal.pone.0239235. eCollection 2020.
3
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
4
Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): A protocol for systematic review and meta analysis.中西医结合治疗2019新型冠状病毒感染患者(COVID-19)的疗效:系统评价与Meta分析方案
Medicine (Baltimore). 2020 Jul 17;99(29):e20781. doi: 10.1097/MD.0000000000020781.
5
Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.中国武汉 1663 例 COVID-19 住院患者的流行病学和临床特征:一项单中心经验。
J Infect Public Health. 2020 Sep;13(9):1202-1209. doi: 10.1016/j.jiph.2020.07.002. Epub 2020 Jul 17.
6
Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis.成人和儿童 COVID-19 患者的合并症、临床体征和症状、实验室检查结果、影像学特征、治疗策略和结局:系统评价和荟萃分析。
Travel Med Infect Dis. 2020 Sep-Oct;37:101825. doi: 10.1016/j.tmaid.2020.101825. Epub 2020 Aug 4.
7
Laboratory findings of COVID-19: a systematic review and meta-analysis.COVID-19 的实验室检测结果:系统评价和荟萃分析。
Scand J Clin Lab Invest. 2020 Oct;80(6):441-447. doi: 10.1080/00365513.2020.1768587. Epub 2020 May 23.
8
Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.亚洲人群中重症与非重症 COVID-19 患者的实验室特征:系统评价和荟萃分析。
Eur J Med Res. 2020 Aug 3;25(1):30. doi: 10.1186/s40001-020-00432-3.
9
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.新型冠状病毒 2019 年 SARS-CoV-2 患者的影像学和临床特征。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.
10
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.中国湖南普通型 2019 冠状病毒病患者的临床特征和药物治疗方法。
Int J Clin Pharm. 2020 Jun;42(3):837-845. doi: 10.1007/s11096-020-01031-2. Epub 2020 May 14.

引用本文的文献

1
Feasibility, utility, usability and acceptance of a multimodal telemonitoring for COVID-19 patients in general practitioners practices in Germany: a mixed methods study with patients.德国全科医生诊所中针对新冠肺炎患者的多模式远程监测的可行性、实用性、易用性及接受度:一项针对患者的混合方法研究
BMC Health Serv Res. 2025 Sep 18;25(1):1203. doi: 10.1186/s12913-025-13455-5.
2
A Machine Learning Approach to Understanding the Genetic Role in COVID-19 Prognosis: The Influence of Gene Polymorphisms Related to Inflammation, Vitamin D, and .一种用于理解基因在COVID-19预后中作用的机器学习方法:与炎症、维生素D相关的基因多态性的影响以及…… (原文最后不完整)
Int J Mol Sci. 2025 Aug 18;26(16):7975. doi: 10.3390/ijms26167975.
3

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案(第六版)
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
3
[Dynamic changes of chest CT imaging in patients with COVID-19].新型冠状病毒肺炎患者胸部CT影像学的动态变化
The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome.
巨噬细胞和单核细胞在新型冠状病毒肺炎严重呼吸综合征中的作用。
Cell Insight. 2025 May 8;4(4):100250. doi: 10.1016/j.cellin.2025.100250. eCollection 2025 Aug.
4
Factors associated with withholding of invasive mechanical ventilation in the early phase of the COVID-19 response and their ethical analyses.新型冠状病毒肺炎应对早期与有创机械通气使用受限相关的因素及其伦理分析。
GHM Open. 2025 Jun 30;5(1):30-36. doi: 10.35772/ghmo.2025.01002.
5
Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers.对具有不同临床表现的新冠肺炎患者进行免疫转录组分析,确定了疾病严重程度标志物。
Sci Rep. 2025 Jul 2;15(1):23416. doi: 10.1038/s41598-025-04837-0.
6
Pharmacoinformatics in identifying therapeutically important chemical species from Ayurvedic formulations employed in treating COVID-19 patients.药物信息学在从用于治疗新冠肺炎患者的阿育吠陀配方中识别具有治疗重要性的化学物质方面的应用。
J Ayurveda Integr Med. 2025 Jun 23;16(4):101161. doi: 10.1016/j.jaim.2025.101161.
7
Epidemiology, Symptoms and Pathophysiology of Long Covid Complications.长期新冠并发症的流行病学、症状及病理生理学
J Cell Immunol. 2024;6(5):219-230. doi: 10.33696/immunology.6.209.
8
Understanding symptom clusters, diagnosis and healthcare experiences in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID: a cross-sectional survey in the UK.了解肌痛性脑脊髓炎/慢性疲劳综合征和长期新冠病毒感染后的症状群、诊断及医疗经历:英国的一项横断面调查
BMJ Open. 2025 Apr 2;15(4):e094658. doi: 10.1136/bmjopen-2024-094658.
9
Determinants of SARS-CoV-2 infection across three sentinels sites in Benin during 2021: A multicentric surveillance study.2021年贝宁三个哨点地区新冠病毒感染的决定因素:一项多中心监测研究
PLOS Glob Public Health. 2025 Feb 13;5(2):e0004227. doi: 10.1371/journal.pgph.0004227. eCollection 2025.
10
Unsupervised machine learning clustering approach for hospitalized COVID-19 pneumonia patients.针对住院COVID-19肺炎患者的无监督机器学习聚类方法。
BMC Pulm Med. 2025 Feb 8;25(1):70. doi: 10.1186/s12890-025-03536-w.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 24;49(2):191-197. doi: 10.3785/j.issn.1008-9292.2020.02.03.
4
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.中国湖北省外指定传染病医院的 COVID-19 疫情。
Allergy. 2020 Jul;75(7):1742-1752. doi: 10.1111/all.14309. Epub 2020 Apr 17.
5
Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.新冠康复患者体内病毒 RNA 的持续存在与清除。
Chin Med J (Engl). 2020 May 5;133(9):1039-1043. doi: 10.1097/CM9.0000000000000774.
6
Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study.江苏省输入性新型冠状病毒肺炎(COVID-19)病例的临床特征:一项多中心描述性研究。
Clin Infect Dis. 2020 Jul 28;71(15):706-712. doi: 10.1093/cid/ciaa199.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.住院的 SARS-CoV-2 感染患者的临床特征:一项单臂荟萃分析。
J Med Virol. 2020 Jun;92(6):612-617. doi: 10.1002/jmv.25735. Epub 2020 Mar 11.
9
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.新型冠状病毒 2019 年 SARS-CoV-2 患者的影像学和临床特征。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.
10
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.